Data / Form D filings / Voxcell BioInnovation Inc.
Voxcell BioInnovation Inc.: Form D filings
Voxcell BioInnovation Inc., a biotechnology company in Victoria, British Columbia, Canada, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on September 1, 2026, reports $2.2 million sold of a $2.2 million offering to 31 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300-637 BAY STREET, Victoria, British Columbia, Canada, V8T 5
- Phone
- (672) 974-8850
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2041826
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | New notice | $2,200,676 | $2,200,676 | 31 | Aug 19, 2026 | sec.gov | |
| Mar 24, 2025 | New notice | $1,733,282 | $1,733,264 | $18 | 10 | Feb 28, 2025 | sec.gov |
| Nov 18, 2024 | New notice | $1,951,738 | $1,536,603 | $415,135 | 38 | Dec 20, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Karolina Papera Valente | Executive Officer, Director | |
| Thomas Neumann | Director | |
| Marie-Helene Raigneau | Director | |
| Jessica Miller | Director | |
| Mark Miller | Director |
Every Form D from the week of Aug 31, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Voxcell BioInnovation Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.